Breaking News Instant updates and real-time market news.

BBY

Best Buy

$38.33

-0.58 (-1.49%)

, GME

GameStop

$26.05

-0.78 (-2.91%)

07:28
10/12/16
10/12
07:28
10/12/16
07:28

Best Buy, GameStop should be able to sidestep Note 7 impact, says SunTrust

SunTrust analyst David Magee, in two separate notes to investors, said that he believes Samsung's (SSNLF) troubles with the Galaxy Note 7 should not translate to shortfalls for either GameStop's (GME) mobile stores or for Best Buy (BBY), as in both cases most of their customers will simply pick different models. Sony's VR headset and other upcoming products in the category are "ideal for customers to try out in stores," added Magee, who keeps a Buy rating on both GameStop and Best Buy.

BBY

Best Buy

$38.33

-0.58 (-1.49%)

GME

GameStop

$26.05

-0.78 (-2.91%)

SSNLF

Samsung

  • 23

    Oct

  • 14

    Nov

BBY Best Buy
$38.33

-0.58 (-1.49%)

08/24/16
WEDB
08/24/16
NO CHANGE
WEDB
Best Buy likely to return to comp sales declines, says Wedbush
Wedbush analyst Michael Pachter says that Best Buy's Q2 results were bolstered by the company's control of promotional activity and by its share repurchases. However, the analyst expects the company's comps to begin to decline persistently due to "a lack of compelling new products" for the holiday season. He thinks that the company's cost cutting is approaching its limit, and he keeps an Underperform rating on the shares.
08/24/16
DBAB
08/24/16
NO CHANGE
Target $41
DBAB
Hold
Best Buy price target raised to $41 from $32 at Deutsche Bank
Deutsche Bank analyst Mike Baker attributes Best Buy's better than expected comparable sales to share gains, which are likely due to leveraging its scale to form strong vendor partnerships, but he also notes that most indicators keep pointing to a weak consumer electronics industry. Baker raised his price target on Best Buy shares to $41 from $32 but keeps a Hold rating on the stock.
08/24/16
08/24/16
NO CHANGE

SunTrust sees reasons to be positive on Best Buy 2H16 outlook
SunTrust analyst David Magee says that Best Buy's Q2 results show that its investments of the last two years are paying off. The analyst thinks that the company will have several positive catalysts in the second half of the year, including new virtual reality and gaming product introductions, along with appliance share gains. These catalysts should enable Best Buy's momentum to continue, according to Magee, who raised his price target on the stock to $45 from $39 and keeps a Buy rating.
GME GameStop
$26.05

-0.78 (-2.91%)

09/09/16
09/09/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Chesapeake (CHK) upgraded to Buy from Hold at Wunderlich with analyst Jason Wangler saying the company's assets are performing and its balance sheet is improving. 2. GameStop (GME) upgraded to Buy from Neutral at Hilliard Lyons. 3. Finisar (FNSR) upgraded to Buy from Neutral at MKM Partners with analyst Michael Genovese saying he is "extremely upbeat on the Optical components/module industry," and Chinese demand for 10G and 100G Optical modules appears it can stay strong for multiple years. 4. Randgold (GOLD) upgraded to Buy from Neutral at UBS with the firm citing the recent pullback in the shares and the potential for a dividend raise in 2017. 5. Teekay LNG (TGP) upgraded to Outperform from Market Perform at Wells Fargo analyst Michael Webber saying the discount to net asset value and the company's progress around financing its order book make the valuation "particularly compelling." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/09/16
HDLY
09/09/16
UPGRADE
Target $33
HDLY
Buy
GameStop upgraded to Buy from Neutral at Hilliard Lyons
Hilliard Lyons analyst Jeffrey Thomison upgraded GameStop to Buy with an unchanged price target of $33.
09/09/16
PIPR
09/09/16
NO CHANGE
PIPR
August NPD video game software sales rose 1%, says Piper Jaffray
Piper Jaffray analyst Michael Olson says August NPD video game software sales were up 1% year-over-year, driven by Sony (SNE) publishing No Man's Sky and Electronic Arts' (EA) Madden NFL 17. The data are most positive for Activision Blizzard (ATVI), which continued to benefit from sell-through of incremental title Overwatch, Olson tells investors in a research note. He believes the monthly numbers are largely irrelevant for Take-Two (TTWO), since NBA 2K17 is due out in September, and GameStop (GME), since the company announced October quarter guidance at the end of August.
SSNLF Samsung

08/01/16
NEED
08/01/16
NO CHANGE
Target $65
NEED
Buy
Synaptics price target lowered to $65 from $88 at Needham
Needham analyst Rajvindra Gill lowered his price target for Synaptics (SYNA) to $65 from $88 on a lower earnings multiple as he remains uncertain on whether the company has secured the OLED DDIC for Apple's (AAPL) iPhone 8 versus an internal Samsung (SSNLF) solution. The analyst reiterates a Buy rating on Synaptics' shares, saying the company will remain one of the leaders in the display markets.
10/12/16
WELS
10/12/16
NO CHANGE
WELS
Market Perform
Wells doesn't see Apple as biggest beneficiary from Samsung issues
Wells Fargo analyst Maynard Um attributes the recent rally in shares of Apple (AAPL), at least in part, to Samsung's (SSNLF) issues with its Note 7 phones. Apple gained an incremental $14B in market capitalization at its intraday peak, which the analyst believes embeds more than 3M of incremental iPhone 7 Plus units. Samsung's production halt will help Apple, but other Android vendors with 5.7 inch phones could see a bigger benefit if Android users prefer to stick with Android, Um tells investors in a research note. He points out that LG, Kyocera, and Microsoft (MFST) have 5.7 inch Android phones at U.S. carriers. Um thinks expectations for Apple into earnings "have risen materially." He keeps a Market Perform rating on the iPhone maker. Apple closed yesterday up 25c to $116.30.
10/11/16
DRXL
10/11/16
NO CHANGE
Target $185
DRXL
Buy
Apple could gain 8M iPhone units from Note 7 troubles, says Drexel Hamilton
Drexel Hamilton analyst Brian White estimates Apple (AAPL) has an opportunity to pick up "at least" 8 million incremental iPhone units in calendar year 2016 due to the Galaxy Note 7 being scrapped, noting that original market expectations were for Samsung (SSNLF) to ship about 10M-14M Galaxy Note 7 units in the second half of this year. The "fiasco" could permanently damage Samsung's smartphone brand, resulting in Apple market share gains, White added. The analyst keeps a Buy rating and $185 price target on Apple shares.

TODAY'S FREE FLY STORIES

FL

Foot Locker

$74.23

0.55 (0.75%)

07:27
12/05/16
12/05
07:27
12/05/16
07:27
Recommendations
Foot Locker analyst commentary  »

Foot Locker price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

NMBL

Nimble Storage

$7.72

0.28 (3.76%)

07:25
12/05/16
12/05
07:25
12/05/16
07:25
Recommendations
Nimble Storage analyst commentary  »

Nimble Storage can…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 12

    Dec

HDYN

Hyperdynamics

07:25
12/05/16
12/05
07:25
12/05/16
07:25
Hot Stocks
Hyperdynamics signs LOI with SAPETRO »

Hyperdynamics (HDYN)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$740.34

-3.31 (-0.45%)

07:25
12/05/16
12/05
07:25
12/05/16
07:25
Recommendations
Amazon.com analyst commentary  »

Amazon to continue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRIL

Trillium Therapeutics

$6.70

-0.5 (-6.94%)

07:25
12/05/16
12/05
07:25
12/05/16
07:25
Conference/Events
Trillium Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

QTNA

Quantenna Communications

$16.83

-0.18 (-1.06%)

07:24
12/05/16
12/05
07:24
12/05/16
07:24
Upgrade
Quantenna Communications rating change  »

Quantenna Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

TRIP

TripAdvisor

$46.46

-0.7 (-1.48%)

07:22
12/05/16
12/05
07:22
12/05/16
07:22
Upgrade
TripAdvisor rating change  »

TripAdvisor upgraded on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSIQ

Canadian Solar

$11.07

-0.21 (-1.86%)

07:21
12/05/16
12/05
07:21
12/05/16
07:21
Hot Stocks
Canadian Solar closes financing for solar power project in Japan »

Canadian Solar announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 09

    Dec

BA

Boeing

$152.25

-0.14 (-0.09%)

, EADSY

Airbus

$15.64

-0.26 (-1.64%)

07:19
12/05/16
12/05
07:19
12/05/16
07:19
Periodicals
Norwegian Air CEO aims to order more Boeing, Airbus aircraft, Reuters reports »

Norwegian Air Shuttle CEO…

BA

Boeing

$152.25

-0.14 (-0.09%)

EADSY

Airbus

$15.64

-0.26 (-1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCLP

Hi-Crush Partners

$18.40

0.6 (3.37%)

07:19
12/05/16
12/05
07:19
12/05/16
07:19
Upgrade
Hi-Crush Partners rating change  »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSN

Tyson Foods

$57.05

0.88 (1.57%)

07:18
12/05/16
12/05
07:18
12/05/16
07:18
Hot Stocks
Tyson Foods creates $150M venture capital fund »

As part of its commitment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

SNSS

Sunesis

$3.90

-0.06 (-1.52%)

07:18
12/05/16
12/05
07:18
12/05/16
07:18
Hot Stocks
Sunesis says SNS-062 on track to begin dosing in Phase 1B/2 trial in 1H17 »

Sunesis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLT

Hilton

$25.26

0.05 (0.20%)

07:18
12/05/16
12/05
07:18
12/05/16
07:18
Hot Stocks
Hilton board approves 1-for-3 reverse stock split; sees spinoff completed Jan. 3 »

Hilton Worldwide Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

TGLS

Tecnoglass

$11.81

-0.1 (-0.84%)

07:17
12/05/16
12/05
07:17
12/05/16
07:17
Hot Stocks
Tecnoglass to acquire Florida-based E.S. Windows in $13M transaction »

Tecnoglass announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$41.57

-0.01 (-0.02%)

07:16
12/05/16
12/05
07:16
12/05/16
07:16
Recommendations
Alnylam analyst commentary  »

Alnylam's fitusiran…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVAX

Dynavax

$4.70

0.35 (8.05%)

07:15
12/05/16
12/05
07:15
12/05/16
07:15
Hot Stocks
Dynavax presents clinical data from SD-101 at ASH meeting »

Dynavax Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

ONCE

Spark Therapeutics

$50.01

0.27 (0.54%)

07:15
12/05/16
12/05
07:15
12/05/16
07:15
Recommendations
Spark Therapeutics analyst commentary  »

Spark may be pressured…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ONTX

Onconova

$2.62

-0.23 (-8.07%)

07:14
12/05/16
12/05
07:14
12/05/16
07:14
Hot Stocks
Onconova presents Phase 2 data from rigosertib/azacitidine combination »

Onconova Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

F

Ford

$12.24

-0.19 (-1.53%)

07:14
12/05/16
12/05
07:14
12/05/16
07:14
Periodicals
Ford still moving small-car production to Mexico, WSJ reports »

Ford Motor is still…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Jan

  • 10

    Jan

GLOG

GasLog

$15.95

0.45 (2.90%)

, GLOP

GasLog Partners

$20.60

-0.05 (-0.24%)

07:14
12/05/16
12/05
07:14
12/05/16
07:14
Hot Stocks
GasLog announces order of FSRU LLIs »

GasLog (GLOG) announces…

GLOG

GasLog

$15.95

0.45 (2.90%)

GLOP

GasLog Partners

$20.60

-0.05 (-0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

VBLT

VBL Therapeutics

$5.25

0.05 (0.96%)

07:13
12/05/16
12/05
07:13
12/05/16
07:13
Hot Stocks
VBL says DSMC recommends Phase 3 GLOBE study continue as planned »

VBL Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$5.15

-0.1 (-1.90%)

07:13
12/05/16
12/05
07:13
12/05/16
07:13
Hot Stocks
Sorrento Therapeutics subsidiary says key endpoints met in ZTlido study »

SCILEX Pharmaceuticals, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ONCE

Spark Therapeutics

$50.01

0.27 (0.54%)

07:12
12/05/16
12/05
07:12
12/05/16
07:12
Hot Stocks
Spark Therapeutics appoints John Furey as COO »

Spark Therapeutics (ONCE)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

OMER

Omeros

$10.91

-0.4 (-3.54%)

07:12
12/05/16
12/05
07:12
12/05/16
07:12
Hot Stocks
Omeros says orphan GPCR program delivers new cancer immunotherapy target »

Omeros announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRX

Xerox

$9.50

0.05 (0.53%)

, CNDT

Conduent

07:12
12/05/16
12/05
07:12
12/05/16
07:12
Hot Stocks
Conduent to present business strategy at investor event »

At its first-ever…

XRX

Xerox

$9.50

0.05 (0.53%)

CNDT

Conduent

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.